Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1831501840
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1245 Wilshire Blvd Ste 303
Los Angeles, CA, 90017
Phone (213) 977-1214
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
46,050 services
Medicare patients, 2024
332
Average age 76
Drug cost, 2024
$3.9M
1,266 prescriptions
Company payments, 2025
$5,962
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sungwon R Kyung was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,872 times for 30 patients. In total Sungwon R Kyung billed 46,050 services in 85 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,872 | 30 | $0.09 | $168 |
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 680 | 11 | $0.01 | $8.86 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 588 | 11 | $0.07 | $43.79 |
| 99214 Office E&M - Established | Office | 509 | 155 | $101.92 | $52K |
| 85025 Blood Count | Office | 235 | 57 | $7.61 | $1,788 |
| 99232 Hospital E&M - Subsequent | Facility | 223 | 118 | $64.86 | $14K |
| 80053 Clinical Chemistry | Office | 189 | 45 | $10.35 | $1,956 |
| 96367 Intravenous Infusion, Hydration | Office | 170 | 32 | $24.49 | $4,164 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 165 | 27 | $1.04 | $172 |
| 96413 Chemotherapy Administration | Office | 144 | 23 | $115.55 | $17K |
| 96127 Behavioral Health Services | Office | 136 | 105 | $3.22 | $438 |
| 99223 Hospital E&M - Initial | Facility | 127 | 119 | $142.68 | $18K |
| 36415 Venipuncture Blood Collection | Office | 124 | 44 | $8.64 | $1,071 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 121 | 29 | $0.64 | $77.79 |
| 96372 Injection Administration | Office | 85 | 30 | $11.81 | $1,004 |
By year: 2022 $186K for 20,314 services; 2023 $320K for 23,146 services; 2024 $1.1M for 46,050 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 235 | 57 | $7.61 | $1,788 |
| 80053 Clinical Chemistry | 189 | 45 | $10.35 | $1,956 |
| 36415 Venipuncture Blood Collection | 124 | 44 | $8.64 | $1,071 |
Medicare prescription drug claims, 2024
In 2024, the drug Sungwon R Kyung prescribed most often to Medicare patients was Letrozole, with 127 prescriptions and refills. In total Sungwon R Kyung wrote 1,266 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 127 | 311 | 40 | $2,450 |
| Anastrozole Generic | 97 | 230 | 32 | $1,464 |
| Lupron Depot Leuprolide Acetate | 77 | 88 | 11 | $173K |
| Ondansetron Hcl Generic | 69 | 69 | 42 | $20K |
| Xtandi Enzalutamide | 55 | 55 | Under 11 | $767K |
| Hydroxyurea Generic | 48 | 61 | Under 11 | $964 |
| Neulasta Pegfilgrastim | 46 | 46 | 16 | $301K |
| Procrit Epoetin Alfa | 44 | 44 | 12 | $86K |
| Zarxio Filgrastim-Sndz | 41 | 41 | 14 | $46K |
| Exemestane Generic | 35 | 66 | 11 | $5,757 |
| Eliquis Apixaban | 33 | 33 | Under 11 | $19K |
| Mirtazapine Generic | 30 | 32 | 15 | $209 |
| Prednisone Generic | 27 | 29 | Under 11 | $49.36 |
| Dexamethasone Generic | 26 | 36 | 17 | $440 |
| Sancuso Granisetron | 26 | 39 | 14 | $39K |
Brand drugs: 483 claims; generic drugs: 783 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sungwon R Kyung $5,962 ($5,962 in general payments such as food, travel and fees) from 50 companies. The largest payer was Janssen Biotech, Inc. with $633.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 21 | $633 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $414 |
| Pfizer Inc. PFE | 18 | $395 |
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $338 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $334 |
| Merck Sharp & Dohme LLC MRK | 11 | $325 |
| Daiichi Sankyo Inc. 4568.T | 16 | $294 |
| Incyte Corporation INCY | 10 | $244 |
| Celgene Corporation BMY | 13 | $244 |
| Genentech USA, Inc. ROG.SW | 9 | $192 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.